Click blue titles to view full text in a new window
Use the selectors at the bottom to turn to the next page in the list of documents
You have found 26 document(s) after clicking the search option in a hot topic entry. Starting with the most recently added or updated of our analyses, the list shows in orange whether the original document was a study, review or some other type of document, year it was published, the type of file you will download when you click the title, and for PDFs its size. In blue is the document’s title; click to download. Below is a brief description. Remember we only list documents relevant to the effectiveness of drug or alcohol interventions in the United Kingdom.
If you have not found what you want you could:
Select from the full range of topics and search options available on our topic search page.
Instead try a free text search for documents which contain the words you specify.
Or try browsing back issues of the magazine or recent bulletins.
Documents are regularly added. Use the e-mail update service to monitor additions.
Try the information services provided by partner agencies.
Tried everything and still no luck? E-mail the Findings editor for help by clicking on this logo
DOCUMENT 2016 HTM file
Harm reduction database Wales: take home naloxone 2015–16
Report charting the roll-out of ‘take-home naloxone’ in Wales up to 2016, a harm-reduction measure implemented to prevent deaths involving opiate-type drugs.
HOT TOPIC 2017 HTM file
Overdose deaths in the UK: crisis and response
One of our selection of hot topics – important issues which sometimes generate heated debate. Why did the fall in UK drug overdose deaths in 2009 to 2012 so decisively reverse in the following years? A life-threatening turn away from harm reduction, or simply an ageing population of heroin users?
HOT TOPIC 2017 HTM file
Overdose antidote naloxone takes harm-reduction centre stage
One of our selection of hot topics – important issues which sometimes generate heated debate. National programmes distributing the opiate overdose antidote naloxone have become the great new hope for curbing the rise in overdose deaths, but England is lagging behind the rest of the UK.
In 2011 Scotland became the first country to fund a national policy of distributing the opiate-blocker naloxone to prevent deaths involving opiate-type drugs. According to this evaluation it did prevent deaths where the effect was most likely to be seen – in the weeks after release from prison.
The first simulation of the cost-effectiveness of supplying naloxone kits to heroin users to enable them to prevent overdose deaths estimates that in the US context these programmes would be well within the range considered a cost-effective health intervention. Findings are likely to broadly apply to the UK, one weak link being whether drug users given the kits actually carry them around.
This real-world implementation of overdose education and nasal naloxone distribution in Massachusetts illustrates the life-saving potential of these programmes.
REVIEW 2016 HTM file
Preventing opioid overdose deaths with take-home naloxone
To aid policymaking, experts commissioned by the European Union’s drug misuse monitoring centre review the evidence and offer guidance on the provision of the medication naloxone, which reverses the effects of drugs like heroin, helping to prevent overdoses becoming fatal.
From the USA’s professional society for clinicians and allied professionals in the field of addiction medicine, comprehensive recommendations on how doctors can use medications to treat addiction to heroin and other opioids.
DOCUMENT 2014 HTM file
Community management of opioid overdose
Experts convened by the World Health Organization judged the risk-benefit profile to be strongly in favour of naloxone distribution to prevent opiate overdose deaths, but also cautioned that this “does not address the underlying causes of opioid overdose”.
Consolidates WHO guidance on HIV prevention, diagnosis, treatment and care for key populations including prisoners and people who inject drugs. Strongly advocates universal access of injectors to needle exchange and of dependent opioid users to indefinite, high dose methadone and buprenorphine maintenance.